4MATSUI K, KODAMA N, NANBA H. Effects of maitake (Grifola frondosa ) D-fraction on the carcinoma angiogenesis[J]. Cancer Letters, 2001, 172(2) : 193-198.
5MIYAKE N, MASUDA Y, MURATA Y, et al. Low molecular weight maitake MD-Fraction (Klasma-MD) hydrolyzed with endo-3-1,6-glucanase of Trichoderma harzianum induces antitumor activities[J]. Mycoscience, 2006, 47(2).. 78-83.
6OHNO N, ADAEHI Y, SUZUKL, et al. Characterization of the antitumor glucan obtained from liquid-cultured Grifola frondosa [ J ]. Chem Pharm Bull, 1986, 34(4) ..1709-1715.
7KUBO K, AOKI H, NANBA H. Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake) [J]. Biol Pharm Bull, 1994, 17(8): 1106-1110.
8UKI M, NORIKO K, HIROKI N. Macrophage J774. i cell is activated by MZ-Fraction (Klasma- MZ ) polysaceharide in Grifola frondosa [ J ]. Mycoscience, 2006, 47(6).-360-366.
9ZHANG YJ, MILLS GL, NAIR MG. Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa [J]. J Agric Food Chem, 2002, 50(26) ..7581-7585.
10YAOITA Y, ISHIZUKA T, KAKUDA R, et al. Structures of new ceramides from the fruit bodies of Grifola frondosa[J]. Chem Pharm Bull. 2000, 48 (9) :1356-1358.
